Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Jun;70(6):1050-7.
doi: 10.1016/j.jaad.2014.02.005. Epub 2014 Mar 20.

An open-label study to evaluate sildenafil for the treatment of lymphatic malformations

Christina Danial  1 , Andrea L Tichy  1 , Umar Tariq  2 , Glenda L Swetman  1 , Phuong Khuu  1 , Thomas H Leung  1 , Latanya Benjamin  1 , Joyce Teng  1 , Shreyas S Vasanawala  2 , Alfred T Lane  3
Affiliations
Clinical Trial

An open-label study to evaluate sildenafil for the treatment of lymphatic malformations

Christina Danial et al. J Am Acad Dermatol. 2014 Jun.

Abstract

Background: Lymphatic malformations can be challenging to treat. Mainstay interventions including surgery and sclerotherapy are invasive and can result in local recurrence and complications.

Objective: We sought to assess the effect of 20 weeks of oral sildenafil on reducing lymphatic malformation volume and symptoms in children.

Methods: Seven children (4 boys, 3 girls; ages 13-85 months) with lymphatic malformations were given oral sildenafil for 20 weeks in this open-label study. The volume of the lymphatic malformation was calculated blindly using magnetic resonance imaging performed before and after 20 weeks of sildenafil. Lymphatic malformations were assessed clinically on weeks 4, 12, 20, and 32. Both the physician and parents evaluated the lymphatic malformation in comparison with baseline.

Results: Four subjects had a lymphatic malformation volume decrease (1.0%-31.7%). In 2 subjects, despite a lymphatic malformation volume increase (1.1%-3.7%), clinical improvement was noted while on sildenafil. One subject had a 29.6% increase in lymphatic malformation volume and no therapeutic response. Lymphatic malformations of all 6 subjects who experienced a therapeutic response on sildenafil softened and became easily compressible. Adverse events were minimal.

Limitations: A randomized controlled trial will be necessary to verify the effects of sildenafil on lymphatic malformations.

Conclusions: Sildenafil can reduce lymphatic malformation volume and symptoms in some children.

Keywords: congenital; lymphatic malformation; macrocystic; magnetic resonance imaging; microcystic; phosphodiesterase-5 inhibitors; sclerotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: All authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Clinical Trial Diagram. MRI, magnetic resonance imaging
Figure 2
Figure 2
Lymphatic malformation (LM). Photographs of subject 4 at baseline (2A, 2C) and after 20-weeks of sildenafil (2B, 2D). Coronal T2-weighted fat-suppressed magnetic resonance images show a microcystic-predominant LM in the left superficial pre-mandibular and pre-maxillary soft tissues at baseline (2E) that decreased by 31.7% in volume after 20 weeks of sildenafil (2F).
See this image and copyright information in PMC

References

    1. Bloom DC, Perkins JA, Manning SC. Management of lymphatic malformations and macroglossia: results of a national treatment survey. Int J Pediatr Otorhinolaryngol. 2009;73:1114–1118. - PubMed
    1. Choi DJ, Alomari AI, Chaudry G, Orbach DB. Neurointerventional management of low-flow vascular malformations of the head and neck. Neuroimaging Clin N Am. 2009;19:199–218. - PubMed
    1. Cahill AM, Nijs E, Ballah D, Rabinowitz D, Thompson L, Rintoul N, et al. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience. J Pediatr Surg. 2011;46:2083–2095. - PubMed
    1. Hassanein AH, Mulliken JB, Fishman SJ, Quatrano NA, Zurakowski D, Greene AK. Lymphatic malformation: risk of progression during childhood and adolescence. J Craniofac Surg. 2012;23:149–152. - PubMed
    1. Faul JL, Berry GJ, Colby TV, Ruoss SJ, Walter MB, Rosen GD, et al. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med. 2000;161:1037–1046. - PubMed

Publication types

MeSH terms

LinkOut - more resources